Showing all 5 results
Solid Tumor Cancer Leukopak
LeukoCore™ Solid Tumor Leukopak products contain enriched leukocytes collected from donors with solid tumors using an IRB-approved apheresis protocol. These leukopaks provide high yields of peripheral blood mononuclear cells (PBMCs)—including T cells, B cells, NK cells, and monocytes—ideal for tumor immunology research, functional immune assays, and preclinical testing of immunotherapies.
Solid Tumor Cancer PBMC
Solid Tumor PBMC samples are isolated from donors with clinically diagnosed solid tumors. Ideal for studying tumor-immune interactions, immune checkpoint regulation, and systemic immune responses across a range of cancers including breast, lung, colorectal, and pancreatic tumors.
Solid Tumor Cancer Plasma
Solid Tumor Plasma samples are collected from donors with confirmed solid tumors. Suitable for analyzing circulating tumor DNA (ctDNA), cytokines, and soluble biomarkers related to tumor burden, metastasis, and treatment response.
Solid Tumor Cancer Serum
Solid Tumor Serum samples are derived from donors with clinically diagnosed solid tumors. Useful for profiling tumor markers, metabolic indicators, and inflammatory proteins linked to disease progression and immune modulation.
Solid Tumor Cancer Whole Blood
Solid Tumor Whole Blood samples are obtained from donors with confirmed solid tumors. Valuable for transcriptomic and genomic analysis, immune profiling, and identifying systemic molecular alterations in cancer.